List of bibliographic references indexed by Substantia Nigra (metabolism)
Number of relevant bibliographic references: 30.
[0-20] [
0 - 20][
0 - 30][
20-29][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000350 (2016) |
Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] ; W R Wayne Martin [Canada] | Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging. |
| 000579 (2015) |
R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis] | Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies. |
| 000587 (2015) |
Abid Oueslati [Suisse, Canada] ; Blaise Lovisa [Suisse] ; John Perrin [Suisse] ; Georges Wagnières [Suisse] ; Hubert Van Den Bergh [Suisse] ; Yanik Tardy [Suisse] ; Hilal A. Lashuel [Suisse, Qatar] | Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease |
| 000655 (2015) |
Kyle Farmer ; Catherine A. Smith ; Shawn Hayley ; Jeffrey Smith | Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease |
| 000716 (2015) |
C. Warren Olanow [États-Unis] ; Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Stewart Factor [États-Unis] ; Nicholas Boulis [États-Unis] ; Mark Stacy [États-Unis] ; Dennis A. Turner [États-Unis] ; William Marks [États-Unis] ; Paul Larson [États-Unis] ; Phillip A. Starr [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard Simpson [États-Unis] ; Ray Watts [États-Unis] ; Barton Guthrie [États-Unis] ; Kathleen Poston [États-Unis] ; Jaimie M. Henderson [États-Unis] ; Matthew Stern [États-Unis] ; Gordon Baltuch [États-Unis] ; Christopher G. Goetz [États-Unis] ; Christopher Herzog [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; Ron Alterman [États-Unis] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. |
| 000789 (2015) |
Christina Poetschke [Allemagne] ; Elena Dragicevic [Allemagne] ; Johanna Duda [Allemagne] ; Julia Benkert [Allemagne] ; Antonios Dougalis [Allemagne] ; Roberta Dezio [Allemagne] ; Terrance P. Snutch [Canada] ; Joerg Striessnig [Autriche] ; Birgit Liss [Allemagne] | Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice |
| 000A47 (2014) |
Jeffrey Graham [Canada] ; Douglas Hobson [Canada] ; Arjuna Ponnampalam [Canada] | High affinity hemoglobin and Parkinson's disease. |
| 000C37 (2013) |
Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. Sadikot | The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress. |
| 000C97 (2013) |
Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. Park | Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)* |
| 001096 (2012) |
Jesse R. Mclean [États-Unis] ; Penelope J. Hallett ; Oliver Cooper ; Michael Stanley ; Ole Isacson | Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression. |
| 001145 (2012) |
Maxime W. C. Rousseaux ; Paul C. Marcogliese ; Dianbo Qu ; Sarah J. Hewitt ; Sarah Seang ; Raymond H. Kim ; Ruth S. Slack ; Michael G. Schlossmacher ; Diane C. Lagace ; Tak W. Mak ; David S. Park [Corée du Sud] | Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease |
| 001A27 (2010) |
Anna Wypijewska [Pologne] ; Jolanta Galazka-Friedman ; Erika R. Bauminger ; Zbigniew K. Wszolek ; Katherine J. Schweitzer ; Dennis W. Dickson ; Andrzej Jaklewicz ; Danek Elbaum ; Andrzej Friedman | Iron and reactive oxygen species activity in parkinsonian substantia nigra. |
| 001D83 (2009) |
W R Wayne Martin [Canada] | Quantitative estimation of regional brain iron with magnetic resonance imaging. |
| 001F18 (2009) |
I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada] | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients |
| 002317 (2008) |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
| 002426 (2007) |
Anthony E. Lang [Canada] | The progression of Parkinson disease: a hypothesis. |
| 002E38 (2003) |
Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent [Canada] ; Doris Doudet | Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration |
| 002E43 (2003) |
Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 003237 (2001) |
Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter |
| 003440 (2000) |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
| 003513 (2000) |
J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Substantia Nigra (metabolism)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Substantia Nigra (metabolism)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Substantia Nigra (metabolism)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
